Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 33-39

  Breccia, Massimo ^a   Mancini, Marco ^a   Nanni, Mauro ^a   D'Elia, Gianna Maria ^a   Carmosino, Ida ^a   Latagliata, Roberto ^a   Sarlo, Chiara ^a   Mandelli, Franco ^a   Alimena, Giuliana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Myelodysplastic syndromes; Normal karyotype; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENETIC RISK; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

ACUTE DISEASE; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HEMORRHAGE; HUMANS; KARYOTYPING; LEUKEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 8444253686     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.05.010     Document Type: Article

References (23)

1. Tricot G., Vlietinck R., Boogaerts M.A., Hendrickx B., De Wolf-Peeters C., Van den Berghe H., et al. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol. 60:1985;19-32
2. Goasguen J.E., Garand R., Bizet M., Bremond J.L., Gardais J., Callat M.P., et al. Prognostic factors of myelodysplastic syndromes - a simplified 3-D scoring system. Leuk Res. 14:1990;255-262
3. Sanz G.F., Sanz M.A., Greenberg P.L. Prognostic factors and scoring systems in myelodysplastic syndromes. Haematologica. 83:1998;358-368
4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189-199
5. Mufti G.J., Stevens J.R., Oscier D.G., Hamblin T.J., Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol. 59:1985;425-433
6. Coiffier B., Adeleine P., Gentilhomme O., Felman P., Treille-Ritouet D., Bryon P.A. Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients. Cancer. 60:1987;3029-3032
7. Sanz G.F., Sanz M.A., Vallespi T., Canizo M.C., Torrabadella M., Garcia S., et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 74:1989;395-408
8. Aul C., Gattermann N., Heyll A., Germing U., Derigs G., Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 6:1992;52-59
9. Morel P., Hebbar M., Lai J.L., Duhamel A., Preudhomme C., Wattel E., et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia. 7:1993;1315-1323
10. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088
11. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. WHO classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting. J Clin Oncol. 17:1999;3835-3849
12. Vallespi T., Imbert M., Mecucci C., Preudhomme C., Fenaux P. Diagnosis, classification, and cytogenetics of myelodysplastic syndromes. Haematologica. 83:1998;258-275
13. Mufti G.J. Chromosomal deletions in the myelodysplastic syndrome. Leuk Res. 16:1992;35-41
14. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481
15. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer. 35:1977;1-39
16. Cox D.R. Regression models and life tables. J. R Stat. Soc. 34:1972;187-220
17. Fenaux P., Morel P., Lai J.L. Cytogenetics of myelodysplastic syndromes. Sem Hematol. 33:1996;127-138
18. Mauritzson N., Johansson B., Albin M., Billstrom R., Ahlgren T., Mikoczy Z., et al. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol. 62:1999;95-102
19. Sole F., Espinet B., Sanz G.F., Cervera J., Calasanz M.J., Luno E., et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol. 108:2000;346-356
20. de Greef G.E., Hagemeijer A. Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes. Baillieres Clin. Haematol. 9:1996;1-18
21. Rigolin G.M., Bigoni R., Milani R., Cavazzini F., Roberti M.G., Bardi A., et al. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia. 15:2001;1841-1847
22. Ketterling R.P., Wyatt W.A., VanWier S.A., Law M., Hodnefield J.M., Hanson C.A., et al. Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH. Leuk Res. 26:2002;235-240
23. Bernasconi P., Cavigliano P.M., Boni M., Calatroni S., Klersy C., Giardini I., et al. Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia. 17:2003;2107-2112